These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6486781)

  • 1. Microbial models of mammalian metabolism: microbial reduction and oxidation of pentoxifylline.
    Davis PJ; Yang SK; Smith RV
    Appl Environ Microbiol; 1984 Aug; 48(2):327-31. PubMed ID: 6486781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial models of mammalian metabolism: stereospecificity of ketone reduction with pentoxifylline.
    Davis PJ; Yang SK; Smith RV
    Xenobiotica; 1985 Dec; 15(12):1001-10. PubMed ID: 3911603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of pentoxifylline and its major metabolites in microbial extracts by thin-layer and high-performance liquid chromatography.
    Smith RV; Yang SK; Davis PJ; Bauza MT
    J Chromatogr; 1983 Dec; 281():281-7. PubMed ID: 6668334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk.
    Bauza MT; Smith RV; Knutson DE; Witter FR
    J Chromatogr; 1984 Sep; 310(1):61-9. PubMed ID: 6501523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of orally administered pentoxifylline in humans.
    Smith RV; Waller ES; Doluisio JT; Bauza MT; Puri SK; Ho I; Lassman HB
    J Pharm Sci; 1986 Jan; 75(1):47-52. PubMed ID: 3958905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of intravenous and oral pentoxifylline in healthy subjects.
    Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A
    Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
    Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
    Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial transformation of hydroxy metabolites of 1-oxohexyl derivatives of theobromine by Cunninghamella echinulata NRRL 1384.
    Pekala E; Kochan M; Carnell AJ
    Lett Appl Microbiol; 2009 Jan; 48(1):19-24. PubMed ID: 19018970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac oxidation/reduction by microbial cultures; microbial models of mammalian metabolism.
    Davis PJ; Guenthner LE
    Xenobiotica; 1985 Oct; 15(10):845-57. PubMed ID: 4072250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of protriptyline by filamentous fungi and yeasts.
    Duhart BT; Zhang D; Deck J; Freeman JP; Cerniglia CE
    Xenobiotica; 1999 Jul; 29(7):733-46. PubMed ID: 10456691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography.
    Luke DR; Rocci ML
    J Chromatogr; 1986 Jan; 374(1):191-5. PubMed ID: 3949928
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of pentoxifylline clearance by cimetidine.
    Luke DR; Rocci ML; Hoholick C
    J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of valdecoxib by microbial cultures.
    Keshetti S; Ciddi V
    J Microbiol Biotechnol; 2010 Apr; 20(4):809-16. PubMed ID: 20467258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography.
    Rieck W; Platt D
    J Chromatogr; 1984 Feb; 305(2):419-27. PubMed ID: 6707169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of celecoxib using microbial cultures.
    Srisailam K; Veeresham C
    Appl Biochem Biotechnol; 2010 Apr; 160(7):2075-89. PubMed ID: 19898964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective biotransformation of pentoxifylline into lisofylline using wine yeast biocatalysis.
    Pekala E; Wójcik T
    Acta Pol Pharm; 2007; 64(2):109-13. PubMed ID: 17665859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of oxpentifylline and four metabolites in plasma and urine by automated capillary gas chromatography using nitrogen-selective detection.
    Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():187-98. PubMed ID: 4086540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of pentoxifylline and its 5-hydroxy metabolite in human plasma by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Musch G; Hamoir T; Massart DL
    J Chromatogr; 1989 Oct; 495():215-26. PubMed ID: 2613806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of plasminogen activator by pentoxifylline and its major metabolite.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1987 Jun; 46(5):747-50. PubMed ID: 3629547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.